Tumors “educate” platelets (TEPs) by altering the platelet RNA profile
TEPs provide a RNA biosource for pan-cancer, multiclass, and companion diagnostics
TEP-based liquid biopsies may guide clinical diagnostics and therapy selection
A total of 100–500 pg of total platelet RNA is sufficient for TEP-based diagnostics